Keurig Dr Pepper Reaffirms Buy at $42, Adds Two Independent Directors
Hedge funds named Keurig Dr Pepper among top sugar stocks while RBC Capital reaffirmed its Buy rating with a $42 price target on February 19. The company appointed Amie Thuener and Bill Newlands to its board and targets early-Q2 closing of the JDE Peet’s deal ahead of a planned spin-off.
1. Hedge Fund Endorsement and Analyst Rating
Keurig Dr Pepper was highlighted by several hedge funds as a leading sugar stock in late February, reinforcing investor confidence in its beverage portfolio. On February 19, RBC Capital reaffirmed a Buy rating on the shares and set a price target of $42, signaling optimism about near-term upside.
2. Board of Directors Overhaul
Effective March 2, the company will expand its board with the additions of Amie Thuener and William “Bill” Newlands as independent directors. The existing Remuneration & Nominating Committee will be split into two distinct bodies—Nominating & Governance and Compensation—to enhance oversight and align with best governance practices.
3. JDE Peet’s Acquisition and Spin-Off Plans
Keurig Dr Pepper expects to close its JDE Peet’s acquisition in early Q2, marking a major step in its growth strategy. Following the deal, management will progress toward separating into two publicly traded entities—Beverage Co. and Global Coffee Co.—to unlock shareholder value.
4. Upcoming Q4 Earnings Release
The company is set to report fiscal fourth-quarter and full-year 2025 results before market open on February 24. Investors will be watching revenue trends across its U.S. Refreshment Beverages, U.S. Coffee and International segments for signs of margin pressure or growth acceleration.